Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2026 it was 210M, up 64.5% from the year before. Over ten years it grew 34.7% a year on average. The highest annual figure on record is 210M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 210M | +64.5% |
| FY2025 | Jun 30, 2025 | 128M | +75.3% |
| FY2024 | Jun 30, 2024 | 73M | +50.3% |
| FY2023 | Jun 30, 2023 | 49M | +0.9% |
| FY2022 | Jun 30, 2022 | 48M | +41.8% |
| FY2021 | Jun 30, 2021 | 34M | +89.6% |
| FY2020 | Jun 30, 2020 | 18M | +45.3% |
| FY2019 | Jun 30, 2019 | 12M | +15.3% |
| FY2018 | Jun 30, 2018 | 11M | 0.0% |
| FY2017 | Jun 30, 2017 | 11M | 0.0% |
| FY2016 | Jun 30, 2016 | 11M | – |
See a number that looks wrong?